The effect of enzyme induction on the metabolism of disopyramide in man
- PMID: 7213529
- PMCID: PMC1401616
- DOI: 10.1111/j.1365-2125.1981.tb00535.x
The effect of enzyme induction on the metabolism of disopyramide in man
Abstract
1 The effects of rifampicin, phenytoin, and disopyramide treatments on the metabolism of disopyramide were studied in patients and volunteers. 2 Rifampicin treatment markedly increased the metabolism of disopyramide. 3 Phenytoin had effects similar to those of rifampicin. The effect subsided in 2 weeks after stopping the treatment. 4 The metabolism of disopyramide seemed fastest in the patient group with the higher dose of disopyramide. Both in patients and volunteers a significant increase occurred in the urinary mono-N-dealkyldisopyramide/disopyramide ratio during the first week of disopyramide therapy. This change can partly be due to pharmacokinetic differences between disopyramide and its metabolite. The inducing effect of disopyramide remained uncertain.
Similar articles
-
Enhanced metabolism and diminished efficacy of disopyramide by enzyme induction?Br J Clin Pharmacol. 1980 Feb;9(2):149-52. doi: 10.1111/j.1365-2125.1980.tb05825.x. Br J Clin Pharmacol. 1980. PMID: 7356902 Free PMC article.
-
Disopyramide concentrations in saliva.Int J Clin Pharmacol Ther Toxicol. 1982 Feb;20(2):68-72. Int J Clin Pharmacol Ther Toxicol. 1982. PMID: 7061181
-
Plasma concentrations and protein binding of disopyramide and mono-N-dealkyldisopyramide during chronic oral disopyramide therapy.Br J Clin Pharmacol. 1981 Apr;11(4):369-75. doi: 10.1111/j.1365-2125.1981.tb01134.x. Br J Clin Pharmacol. 1981. PMID: 7259930 Free PMC article.
-
Clinical pharmacokinetics of disopyramide.J Pharmacokinet Biopharm. 1982 Oct;10(5):465-94. doi: 10.1007/BF01059032. J Pharmacokinet Biopharm. 1982. PMID: 6762414 Review. No abstract available.
-
[Clinical pharmacology of anti-arrhythmia agents. I. Quinidine, procainamide and disopyramide].Kardiol Pol. 1981;24(7):505-17. Kardiol Pol. 1981. PMID: 7024612 Review. Polish. No abstract available.
Cited by
-
Antiarrhythmic agents: drug interactions of clinical significance.Drug Saf. 2000 Dec;23(6):509-32. doi: 10.2165/00002018-200023060-00003. Drug Saf. 2000. PMID: 11144659 Review.
-
Clinically significant interactions with drugs used in the treatment of tuberculosis.Drug Saf. 2002;25(2):111-33. doi: 10.2165/00002018-200225020-00005. Drug Saf. 2002. PMID: 11888353 Review.
-
Plasma concentration of disopyramide given as capsules and controlled release tablets.Eur J Clin Pharmacol. 1983;24(2):199-203. doi: 10.1007/BF00613817. Eur J Clin Pharmacol. 1983. PMID: 6840167
-
Therapeutic drug monitoring of antiarrhythmic agents.Clin Pharmacokinet. 1982 Mar-Apr;7(2):125-48. doi: 10.2165/00003088-198207020-00003. Clin Pharmacokinet. 1982. PMID: 7039925 Review. No abstract available.
-
Adverse effects of class I antiarrhythmic drugs.Drug Saf. 1997 Jul;17(1):8-36. doi: 10.2165/00002018-199717010-00002. Drug Saf. 1997. PMID: 9258628 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources